Huang WK - Search Results

1

Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive Bladder Cancer Declining Definitive Local Therapy.

Chang PH, Chen HY, Chang YS, Su PJ, Huang WK, Lin CF, Hsieh JC, Wu CT. Chang PH, et al. Among authors: huang wk. Cancers (Basel). 2024 Feb 23;16(5):894. doi: 10.3390/cancers16050894. Cancers (Basel). 2024. PMID: 38473256 Free PMC article.

2

Everolimus in metastatic renal cell carcinoma: preliminary experience from Chang Gung Memorial Hospital.

Huang WK, Liaw CC, Pang ST, Chuang CK, Chiang YJ, Wu CT, Chang YH, Wang HM, Lin YC, Hsieh JJ, Ou LY, Tsai SI, Yang CH, Yang CT, Chang JW. Huang WK, et al. Chang Gung Med J. 2012 Sep-Oct;35(5):402-7. doi: 10.4103/2319-4170.105478. Chang Gung Med J. 2012. PMID: 23127345 Free article.

3

A Simple Risk Model to Predict Survival in Patients With Carcinoma of Unknown Primary Origin.

Huang CY, Lu CH, Yang CK, Hsu HC, Kuo YC, Huang WK, Chen JS, Lin YC, Chia-Yen H, Shen WC, Chang PH, Yeh KY, Hung YS, Chou WC. Huang CY, et al. Among authors: huang wk. Medicine (Baltimore). 2015 Nov;94(47):e2135. doi: 10.1097/MD.0000000000002135. Medicine (Baltimore). 2015. PMID: 26632736 Free PMC article.

4

Circulating Tumour Cells as an Independent Prognostic Factor in Patients with Advanced Oesophageal Squamous Cell Carcinoma Undergoing Chemoradiotherapy.

Su PJ, Wu MH, Wang HM, Lee CL, Huang WK, Wu CE, Chang HK, Chao YK, Tseng CK, Chiu TK, Lin NM, Ye SR, Lee JY, Hsieh CH. Su PJ, et al. Among authors: huang wk. Sci Rep. 2016 Aug 17;6:31423. doi: 10.1038/srep31423. Sci Rep. 2016. PMID: 27530152 Free PMC article. Clinical Trial.

5

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer.

Chou WC, Wu MH, Chang PH, Hsu HC, Chang GJ, Huang WK, Wu CE, Hsieh JC. Chou WC, et al. Among authors: huang wk. Int J Biol Sci. 2018 Jan 12;14(2):137-146. doi: 10.7150/ijbs.23182. eCollection 2018. Int J Biol Sci. 2018. PMID: 29483832 Free PMC article.

6

The Prognostic Roles of Pretreatment Circulating Tumor Cells, Circulating Cancer Stem-Like Cells, and Programmed Cell Death-1 Expression on Peripheral Lymphocytes in Patients with Initially Unresectable, Recurrent or Metastatic Head and Neck Cancer: An Exploratory Study of Three Biomarkers in One-time Blood Drawing.

Chang PH, Wu MH, Liu SY, Wang HM, Huang WK, Liao CT, Yen TC, Ng SH, Chen JS, Lin YC, Lin HC, Hsieh JC. Chang PH, et al. Among authors: huang wk. Cancers (Basel). 2019 Apr 15;11(4):540. doi: 10.3390/cancers11040540. Cancers (Basel). 2019. PMID: 30991692 Free PMC article.

7

Baseline circulating stem-like cells predict survival in patients with metastatic breast Cancer.

Lee CH, Hsieh JC, Wu TM, Yeh TS, Wang HM, Lin YC, Chen JS, Lee CL, Huang WK, Hung TM, Yen TT, Chan SC, Chou WC, Kuan FC, Hu CC, Chang PH. Lee CH, et al. Among authors: huang wk. BMC Cancer. 2019 Dec 2;19(1):1167. doi: 10.1186/s12885-019-6370-1. BMC Cancer. 2019. PMID: 31791269 Free PMC article.

8

A Nomogram Predicting Progression Free Survival in Patients with Gastrointestinal Stromal Tumor Receiving Sunitinib: Incorporating Pre-Treatment and Post-Treatment Parameters.

Chang YR, Huang WK, Wang SY, Wu CE, Chen JS, Yeh CN. Chang YR, et al. Among authors: huang wk. Cancers (Basel). 2021 May 25;13(11):2587. doi: 10.3390/cancers13112587. Cancers (Basel). 2021. PMID: 34070456 Free PMC article.

9

Gonadotropin-releasing hormone antagonist associated with lower cardiovascular risk compared with gonadotropin-releasing hormone agonist in prostate cancer: A nationwide cohort and in vitro study.

Chen DY, Su PJ, See LC, Liu JR, Chuang CK, Pang ST, Tseng CN, Chen SW, Hsieh IC, Chu PH, Lin YC, Hsu CL, Chang JW, Lin MS, Pang JS, Hsieh MJ, Huang WK. Chen DY, et al. Among authors: huang wk. Prostate. 2021 Sep;81(12):902-912. doi: 10.1002/pros.24187. Epub 2021 Jul 1. Prostate. 2021. PMID: 34196430

10

Establishment of a Pretreatment Nomogram to Predict the 6-Month Mortality Rate of Patients with Advanced Biliary Tract Cancers Undergoing Gemcitabine-Based Chemotherapy.

Wu CE, Huang WK, Chou WC, Hsieh CH, Chang JW, Lin CY, Yeh CN, Chen JS. Wu CE, et al. Among authors: huang wk. Cancers (Basel). 2021 Jun 23;13(13):3139. doi: 10.3390/cancers13133139. Cancers (Basel). 2021. PMID: 34201707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page